PDL (Prescription Drug List) in California refers to the preferred medication list maintained by health plans to help control prescription costs while ensuring access to effective treatments. When a doctor prescribes medication, the plan checks whether the drug is on its PDL. If it is, patients pay the standard copay or coinsurance. If the medication is not on the list, patients typically face higher out-of-pocket costs.
California health plans, including those regulated by the Department of Managed Health Care (DMHC), use PDLs as a cost-management tool. Plans must follow state regulations requiring them to include a reasonable number of drugs in each therapeutic category and ensure patients can access medically necessary medications. Doctors can request exceptions or prior authorizations for non-PDL drugs if they believe the preferred alternative is inadequate for a patient's condition.
Medicare Advantage plans in California also maintain formularies (similar to PDLs) under federal guidelines. The state has specific rules about how plans must communicate their lists to members, including providing updated information regularly.
Patients who receive a non-preferred drug can appeal coverage decisions. Insurers must respond to these appeals within specified timeframes. Additionally, California law allows certain protections—for instance, plans cannot suddenly remove medications that patients are already taking mid-year without proper notice and alternatives.
The goal is to balance cost control with patient access to necessary medications. Factors influencing which drugs appear on lists include efficacy, safety, cost, and clinical evidence. Each health plan in California can maintain its own PDL, though they often follow similar guidelines based on professional recommendations and clinical studies.